Clinical trials have now finished, and Foundayo is in its regulatory stage, meaning it's waiting for approval to be sold in the UK and other countries
Researchers with metabolic syndrome, elevated liver enzymes, or suspected NAFLD have a metabolic profile that aligns well with the dual benefits of tirzepatide (glycemic control, appetite reduction) and levocarnitine (enhanced hepatic fat oxidation, improved insulin sensitivity at the cellular level)
Severe cutaneous adverse reactions to drugs (SCAR): definitions, diagnostic criteria, genetic predisposition
They are designed to mimic the GLP-1 hormone, which plays a role in regulating blood sugar levels and appetite
However, no attempt was made to ascertain if the available number of patients on GLP-1 agonist use or the number of events were enough for definitive conclusions